Potassium Channel, Voltage-Gated, KQT-Like Subfamily, Member 1

Alternative Names

  • KCNQ1
  • Potassium Channel, Voltage-Gated, Shaker-Related Subfamily, Member 9
  • KVLQT1
  • KCNA9
  • KCNA8
Back to search Result
OMIM Number

607542

NCBI Gene ID

3784

Uniprot ID

P51787

Length

404427 bases

No. of Exons

17

No. of isoforms

2

Protein Name

Potassium voltage-gated channel subfamily KQT member 1

Molecular Mass

74699Da

Amino Acid Count

676

Genomic Location

chr11:2444684-2849110

Gene Map Locus
11p15.5-p15.4

Description

KCNQ1 gene encodes a protein named potassium voltage-gated channel subfamily KQT member 1 that plays a critical role in regulating repolarisation phase of the cardiac action potential as well as in controlling the water and salt homeostasis in several epithelial tissues. Mutations in KCNQ1 gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. These mutations affect the voltage-gated K+ channel resulting in reduction of potassium ion transport, thereby, altering the transmission of electrical signals in the heart and consequently increasing the risk of syncope or sudden death to occur.

Epidemiology in the Arab World

View Map
Variant NameCountryGenomic LocationClinvar Clinical SignificanceCTGA Clinical Significance Condition(s)HGVS ExpressionsdbSNPClinvar
NM_000218.2:c.1251+1G>TSaudi ArabiaNC_000011.10:g.2587693G>TUncertain SignificanceJervell and Lange-Nielsen Syndrome 1NG_008935.1:g.147703G>T; NM_000218.2:c.1251+1G>T
NM_000218.2:c.1700T>CSaudi ArabiaNC_000011.10:g.2777000T>CLikely Pathogenic, PathogenicPathogenicJervell and Lange-Nielsen Syndrome 1NG_008935.1:g.337010T>C; NM_000218.2:c.1700T>C; NP_000209.2:p.Ile567Thr19947280553007
NM_000218.2:c.1795-11803A>CLebanonNC_000011.10:g.2835964A>CAssociationType 2 Diabetes MellitusNG_008935.1:g.395974A>C; NM_000218.2:c.1795-11803A>C; NP_000209.2:p.?2237895
NM_000218.2:c.1795-29246C>TLebanonNC_000011.10:g.2818521C>TAssociation, BenignType 2 Diabetes MellitusNG_008935.1:g.378531C>T; NM_000218.2:c.1795-29246C>T; NP_000209.2:p.?2237892
NM_000218.2:c.387-5T>ASaudi Arabiachr11:2527923PathogenicPathogenicLong QT Syndrome 1NG_008935.1:g.87933T>A; NM_000218.2:c.387-5T>A200872
NM_000218.2:c.604G>ASaudi ArabiaNC_000011.10:g.2570754G>APathogenicUncertain SignificanceJervell and Lange-Nielsen Syndrome 1NG_008935.1:g.130764G>A; NM_000218.2:c.604G>A; NP_000209.2:p.Asp202Asn19947270253077
NM_000218.2:c.773A>CSaudi Arabiachr11:2572102PathogenicPathogenicLong QT Syndrome 1NG_008935.1:g.132112A>C; NM_000218.2:c.773A>C; NP_000209.2:p.His258Pro19947271867105
NM_000218.2:c.817C>TSaudi ArabiaNC_000011.10:g.2572882C>TPathogenicPathogenic, Uncertain SignificanceJervell and Lange-Nielsen Syndrome 1NG_008935.1:g.132892C>T; NM_000218.2:c.817C>T ; NP_000209.2:p.Leu273Phe1200741803119
NM_000218.2:c.820_830delSaudi ArabiaNC_000011.10:g.2572885_2572895Uncertain SignificanceJervell and Lange-Nielsen Syndrome 1NG_008935.1:g.132895_132905del; NM_000218.2:c.820_830del; NP_000209.2:p.Ile274Valfs*7
NM_000218.3:c.1484_1485CT[1]Saudi ArabiaNC_000011.10:g.2662051_2662052CT[1]Pathogenic, Uncertain SignificancePathogenic, Uncertain SignificanceJervell and Lange-Nielsen Syndrome 1NG_008935.1:g.222061_222062CT[1]; NM_000218.3:c.1484_1485CT[1]; NP_861463.1:p.Leu369fs39750809052983
NM_000218.3:c.1591C>TLebanonNC_000011.10:g.2775960C>TPathogenicLikely PathogenicLong QT Syndrome 1NG_008935.1:g.335970C>T; NM_000218.3:c.1591C>T; NP_000209.2:p.Gln531Ter965523
© CAGS 2024. All rights reserved.